Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

NCT00857220 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia
Attention Deficit Hyperactivity Disorder

Interventions

DRUG: eszopiclone
DRUG: eszopiclone

Sponsor

Sumitomo Pharma America, Inc.